News Archives - QualityStocks

TuesdayMar 10, 2026 12:00 pm

TechForce Robotics (NGTF) Expands Robotics-as-a-Service, Strengthening Its Position in Hospitality Automation

NGTF reported $2.97M in revenue, highlighting growth in RaaS and hospitality operations Nightfood Holdings leverages AI-driven robots to optimize service workflows and cut down on labor costs These updates reflect the company’s broader mission: redefining operational efficiency through autonomous solutions Nightfood Holdings (d.b.a. TechForce Robotics) (OTCQB: NGTF) is entering a defining chapter in its corporate evolution. The company continues to make expanded inroads into the hospitality and service automation sector, combining AI, robotics, and flexible business models to meet the increased demand for efficiency. According to its recently filed Form 10-Q for the period ended Dec 31, 2025, NGTF reported…

TuesdayMar 10, 2026 11:15 am

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) Initiates Commercial Evaluation of Canada’s First Confirmed Subsurface Natural Hydrogen System

Disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) and may include paid advertising. MAX Power outlined the next phase of its development plan, following its confirmation of Canada’s first-ever natural hydrogen subsurface system at its Lawson site near Central Butte. A cornerstone of the next phase is the commencement of a 3D seismic survey across a 47-square-kilometer area at Lawson, with all required permits and approvals in place. MAX Power has also identified more than 80 additional subsurface structures along the Genesis Trend that display geological features analogous to those at Lawson. MAX Power Mining (CSE:…

TuesdayMar 10, 2026 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Key Federal Milestone for RapidSX Platform

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Submission of report completes phase 1 of Ucore’s contract with the U.S. Department of Defense to demonstrate the technical capabilities of its RapidSX rare earth separation platform. The DoD has identified rare earth processing as a strategic priority under its industrial base strengthening initiatives. RapidSX combines aspects of conventional solvent extraction with modern column-based design to enable faster throughput, reduced footprint and potentially lower capital and operating costs. Submitting a final technical report to a federal partner is more than a procedural step;…

TuesdayMar 10, 2026 9:45 am

Unlocking Alaska’s Critical Corridor: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Is Well Positioned in America’s Future Mineral Supply Chain

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. The Department of the Interior’s decision to open 2.1 million acres in Alaska’s Dalton Corridor clears a path for expanded mining access tied to the Ambler Road. Trilogy Metals holds a 50% interest in Ambler Metals, which owns 100% of the Upper Kobuk Mineral Projects spanning 190,929 hectares in the Ambler Mining District. The Arctic deposit hosts 46.7 million tonnes of probable mineral reserves grading 2.11% copper, alongside zinc, lead, gold and silver credits, positioning it among the highest-grade copper projects globally. The…

TuesdayMar 10, 2026 9:16 am

QualityStocksNewsBreaks – Frontieras North America to Host Groundbreaking for West Virginia Commercial Facility

Frontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, announced it will host a groundbreaking ceremony on April 2, 2026, for its first commercial facility in Mason County, West Virginia. The estimated $850 million industrial project is expected to create approximately 300 full-time jobs with wages averaging three times the area’s average income, along with about 2,000 construction jobs during the build phase. The ceremony, scheduled for 11:30 a.m. ET, will include remarks from company leadership and federal and state officials, followed by a ceremonial groundbreaking. The company’s FASForm(TM) technology is designed to convert coal…

TuesdayMar 10, 2026 9:00 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Adopts Shareholder Rights Plan

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has adopted a Shareholder Rights Plan and entered into a Shareholder Rights Plan Agreement with TMX Trust Company as rights agent, effective immediately. The plan, which is consistent with similar measures adopted by Canadian public companies and was not implemented in response to any specific takeover proposal, is designed to provide the company’s board and shareholders adequate time to evaluate any unsolicited takeover bid, explore value-enhancing alternatives and ensure shareholders receive full and fair value. The plan will be subject to…

TuesdayMar 10, 2026 9:00 am

Beeline Holdings Inc. (NASDAQ: BLNE) Sets March 30 Call to Review Q4 Results, Including a $100M Run Rate by December 2027

Beeline Holdings will host a stakeholder call on March 30 to discuss Q4 2025 financial results and operational updates. The company reported quarterly double-digit revenue growth in 2025 and ended the year with over $50 million in Balance Sheet equity and no corporate debt. Beeline is scaling an AI-driven mortgage platform designed to shorten closing times and lower origination costs, and is expanding core mortgage, title, and home equity offerings heading into 2026. The company is positioning its products for millennials, gig-economy workers, and real estate investors, and recently introduced a blockchain-enabled home equity product, building SaaS revenue channels. Beeline…

MondayMar 09, 2026 12:00 pm

Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergy

LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients Specifically, Liora’s Linac for Image Guided Hadron Therapy (“LiGHT”) System and LIXTE’s LB-100 work together to fight cancer As a result, the companies are building a new cancer care ecosystem that hopes to boost the effectiveness of treatments, while also help them be more accessible for a wider range of patients Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy. Specifically,…

MondayMar 09, 2026 11:15 am

Renewal Fuels Inc. (RNWF) Expands Leadership and Targets 2026 Milestone for Texatron(TM) Fusion Platform

Appointment of fusion researcher Fabrice David adds scientific oversight as commercialization plans advance. Travis Yakimishyn joins as Chief Electrical & Power Systems Officer to lead utility-scale integration. The company is transitioning to American Fusion Inc. following its merger with Kepler Fusion Technologies, with filing and audits nearing completion as the company prepares for SEC reporting status. Management reiterates goal of deploying a 100-megawatt operational unit by year-end 2026, with Kepler‘s plan to sell electricity on a per-kilowatt basis to utilities and industrial customers. Renewal Fuels (OTC: RNWF) (d/b/a American Fusion), an advanced energy platform company focused on the development and…

MondayMar 09, 2026 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Secures Key European Milestone for Dusquetide Development

“The EMA's positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO. The designation provides incentives that may include protocol assistance, reduced regulatory fees and up to 10 years of market exclusivity following approval. Dusquetide is classified as an innate defense regulator, a type of compound designed to modulate the body’s innate immune system rather than suppress it outright. For patients living with rare inflammatory diseases, regulatory milestones can mark the difference between stalled research and meaningful therapeutic progress. A positive opinion from the European Medicines Agency (EMA) not only validates a…

Site Search

Company Search

Category: News